ST. LOUIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE ...
Four new interventional labs across Northlake and Southlake campuses enable minimally invasive procedures with improved imaging, reduced radiation and enhanced clinician and patient experience ...
Dr. Atul Gupta, CMO of diagnosis and treatment at Philips, and Kevin Roesch, assistant VP of cardiology and imaging services for Methodist Hospitals, highlight the process of developing interventional ...
ST. LOUIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results